V
V. S. Nadarajan
Researcher at University of Malaya
Publications - 37
Citations - 859
V. S. Nadarajan is an academic researcher from University of Malaya. The author has contributed to research in topics: Population & Imatinib mesylate. The author has an hindex of 11, co-authored 32 publications receiving 776 citations. Previous affiliations of V. S. Nadarajan include University Malaya Medical Centre.
Papers
More filters
Journal ArticleDOI
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.
King Pan Ng,Axel M. Hillmer,Charles Chuah,Charles Chuah,Wen Chun Juan,Tun Kiat Ko,Audrey S.M. Teo,Pramila N. Ariyaratne,Naoto Takahashi,Kenichi Sawada,Yao Fei,Yao Fei,Sheila Soh,Wah Heng Lee,John W.J. Huang,John Carson Allen,Xing Yi Woo,Niranjan Nagarajan,Vikrant Kumar,Anbupalam Thalamuthu,Wan Ting Poh,Ai Leen Ang,Hae Tha Mya,Gee Fung How,L.Y. Yang,Liang Piu Koh,Balram Chowbay,Chia-Tien Chang,V. S. Nadarajan,Wee Joo Chng,Hein Than,Lay Cheng Lim,Yeow Tee Goh,Shenli Zhang,Dianne Poh,Patrick Tan,Patrick Tan,Ju Ee Seet,Mei-Kim Ang,Noan-Minh Chau,Quan Sing Ng,Daniel Shao-Weng Tan,Manabu Soda,Kazutoshi Isobe,Markus M. Nöthen,Tien Yin Wong,Atif Shahab,Xiaoan Ruan,Valere Cacheux-Rataboul,Wing-Kin Sung,Eng Huat Tan,Yasushi Yatabe,Hiroyuki Mano,Hiroyuki Mano,Ross A. Soo,Tan Min Chin,Wan-Teck Lim,Yijun Ruan,Yijun Ruan,S. Tiong Ong +59 more
TL;DR: The results offer an explanation for the heterogeneity of TKI responses across individuals and suggest the possibility of personalizing therapy with BH3 mimetics to overcome BIM-polymorphism–associated TKI resistance.
Journal ArticleDOI
Genetic polymorphisms of human platelet antigens-1 to -6, and -15 in the Malaysian population
TL;DR: The allele frequencies of HPA in Malays and Chinese were found to be similar those of other East and South-East Asian populations, while those of Indians were comparable to the frequencies found in Europeans.
Journal ArticleDOI
A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
TL;DR: A 60-year-old man who initially presented with phenotype of polycythemia vera, which evolved into chronic myeloid leukemia and back to PV once treatment with imatinib was commenced, implies that two independent clones exist with the JAK2 V617F clone only achieving clonal dominance when BCR-ABL positive clones are suppressed by imatinIB.
Journal Article
Anaemia and iron status among blood donors in a blood transfusion unit in Malaysia
V. S. Nadarajan,Geok Im Eow +1 more
TL;DR: It is concluded that a high prevalence of iron deficiency is present among regular male blood donors and all female donors and the use of the copper sulphate screening test as a sole criterion for anaemia screening should be reviewed.
Journal ArticleDOI
Use of red blood cell indices for the identification of iron deficiency among blood donors
TL;DR: The parameter RBC‐Y can be useful as a screening measure for iron deficiency in blood donors, and compare favourably with haemoglobin which only showed a sensitivity of 50%, although specificity was 91% at a cut‐off value of 125 g L−1.